Clinical analysis on the analgesic effect of Methyl Carboprost and Diclofenac Sodium for intracavitary brachytherapy  

卡孕栓、双氯芬酸钠栓在宫颈癌后装放疗术中镇痛效果的临床分析(英文)

作　　者：Guiling Li Yingqiu Song Fang Zhu Tingting Zhang 

机构地区：[1]The Cancer Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430023, China

出　　处：《The Chinese-German Journal of Clinical Oncology》2007年第5期497-499,共3页中德临床肿瘤学杂志（英文版）

摘　　要：Objective:To observe the effects of Methyl Carboprost and Diclofenac Sodium on opening orifice of uterus and pain controlling in patients with uterine cervix cancer (UCC) when receiving intracavitary brachytherapy. Methods: Sixty patients with UCC of stage IIA-IIIB were divided into three groups randomly before receiving the intracavitary brachytherapy: the patients in group A received Methyl Carboprost in the hind fornix of the vagina, group B received Diclofenac Sodium in the anus, while group C was the control group. Results: The painlessness rates in groups A, B and C were 89.9%, 91.3% and 36.4%, respectively. The incidences of patients with relaxed uterus cervix in groups A, B and C were 91.7%, 85.9% and 48.9%, respectively. Conclusion: Methyl Carboprost and Diclofenac Sodium are useful in relaxing uterus cervix and pain controlling in patients with UCC when receiving intracavitary brachytherapy.

关 键 词：intracavitary brachytherapy Methyl Carboprost Diclofenac Sodium 

分 类 号：R737.33[医药卫生—肿瘤]